Tirzepatide 10mg

Tirzepatide is an incretin co‑agonist that activates both glucose‑dependent insulinotropic polypeptide (GIP) and GLP‑1 receptors. In research, this dual mechanism is used to interrogate satiety signaling, insulin secretion dynamics, and gastric emptying, with downstream effects on caloric intake and glycemic indices. For laboratory research use only; not for human consumption.